Groupama Asset Managment

Source: SEC Form 13F · as of Mar 2026

Groupama Asset Managment holds 34 biotech & pharma companies tracked by BioSniper, totaling $657.9M in value as of Mar 2026 (SEC Form 13F).

Companies held

34

Total value held

$657.9M

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Groupama Asset Managment — Biotech 13F Holdings & Portfolio | BioSniper